TreeWAS – Variant ID: rs4768903

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
C67.9 Bladder, unspecified	0.000	0.853	0.147
C67 Malignant neoplasm of bladder	0.000	0.857	0.143
C67.4 Posterior wall of bladder	0.000	0.867	0.133
C67.2 Lateral wall of bladder	0.000	0.870	0.130
C67.0 Trigone of bladder	0.000	0.874	0.126
C67.1 Dome of bladder	0.000	0.875	0.125
C67.5 Bladder neck	0.000	0.885	0.115
E11.9 Without complications	0.000	0.889	0.111
C67.6 Ureteric orifice	0.000	0.895	0.105
E10 Insulin-dependent diabetes mellitus	0.000	0.896	0.104
E10.9 Without complications	0.000	0.897	0.103
C67.7 Urachus	0.000	0.897	0.103
E11 Non-insulin-dependent diabetes mellitus	0.000	0.904	0.096
E10.1 With ketoacidosis	0.000	0.904	0.096
E11.3 With ophthalmic complications	0.000	0.907	0.093
E10-E14 Diabetes mellitus	0.000	0.909	0.091
E10.3 With ophthalmic complications	0.000	0.913	0.087
C67.8 Overlapping lesion of bladder	0.000	0.913	0.087
E10.5 With peripheral circulatory complications	0.000	0.914	0.086
E10.8 With unspecified complications	0.000	0.916	0.084
E10.6 With other specified complications	0.000	0.916	0.084
E11.6 With other specified complications	0.000	0.924	0.076
C67.3 Anterior wall of bladder	0.000	0.924	0.075
E11.0 With coma	0.000	0.925	0.075
E10.2 With renal complications	0.000	0.927	0.073
E11.7 With multiple complications	0.000	0.931	0.069
E10.7 With multiple complications	0.000	0.931	0.068
E10.4 With neurological complications	0.000	0.933	0.067
E12 Malnutrition-related diabetes mellitus	0.000	0.935	0.065
E11.4 With neurological complications	0.000	0.935	0.065
E11.1 With ketoacidosis	0.000	0.938	0.062
E10.0 With coma	0.000	0.943	0.057
E11.8 With unspecified complications	0.000	0.951	0.049
E12.9 Without complications	0.000	0.953	0.047
E12.8 With unspecified complications	0.000	0.953	0.047
E12.7 With multiple complications	0.000	0.953	0.047
E12.6 With other specified complications	0.000	0.953	0.047
E12.5 With peripheral circulatory complications	0.000	0.953	0.047
E12.4 With neurological complications	0.000	0.953	0.047
E12.3 With ophthalmic complications	0.000	0.953	0.047
E12.2 With renal complications	0.000	0.953	0.047
E12.1 With ketoacidosis	0.000	0.953	0.047
E12.0 With coma	0.000	0.953	0.047
E13 Other specified diabetes mellitus	0.000	0.954	0.045
E11.5 With peripheral circulatory complications	0.000	0.963	0.037
E14 Unspecified diabetes mellitus	0.000	0.966	0.034
E13.8 With unspecified complications	0.000	0.967	0.033
E13.7 With multiple complications	0.000	0.967	0.033
E13.6 With other specified complications	0.000	0.967	0.033
E13.5 With peripheral circulatory complications	0.000	0.967	0.033
E13.4 With neurological complications	0.000	0.967	0.033
E13.2 With renal complications	0.000	0.967	0.033
E13.1 With ketoacidosis	0.000	0.967	0.033
E13.0 With coma	0.000	0.967	0.033
E13.3 With ophthalmic complications	0.000	0.968	0.031
C64-C68 Malignant neoplasms of urinary tract	0.000	0.972	0.028
E14.6 With other specified complications	0.000	0.973	0.027
E14.8 With unspecified complications	0.000	0.975	0.025
E14.7 With multiple complications	0.000	0.976	0.024
E14.0 With coma	0.000	0.976	0.024
E14.1 With ketoacidosis	0.000	0.976	0.024
E14.3 With ophthalmic complications	0.000	0.976	0.024
E14.4 With neurological complications	0.000	0.976	0.024
E11.2 With renal complications	0.000	0.977	0.023
E14.2 Withrenal complications	0.000	0.978	0.022
C65 Malignant neoplasm of renal pelvis	0.000	0.978	0.022
E14.5 With peripheral circulatory complications	0.000	0.979	0.021
C68 Malignant neoplasm of other and unspecified urinary organs	0.000	0.980	0.020
Z36.3 Antenatal screening for malformations using ultrasound and other physical methods	0.000	0.982	0.018
G81.9 Hemiplegia, unspecified	0.000	0.983	0.017
E13.9 Without complications	0.000	0.984	0.016
C68.0 Urethra	0.000	0.984	0.016
M80.98 Unspecified osteoporosis with pathological fracture (Other)	0.016	0.984	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.000	0.985	0.015
M80.9 Unspecified osteoporosis with pathological fracture	0.015	0.985	0.000
C64 Malignant neoplasm of kidney, except renal pelvis	0.000	0.985	0.015
C68.8 Overlapping lesion of urinary organs	0.000	0.985	0.015
C68.1 Paraurethral glands	0.000	0.985	0.015
M80.90 Unspecified osteoporosis with pathological fracture (Multiple sites)	0.014	0.986	0.000
Z12.0 Special screening examination for neoplasm of stomach	0.014	0.986	0.000
M80.99 Unspecified osteoporosis with pathological fracture (Site unspecified)	0.014	0.986	0.000
C66 Malignant neoplasm of ureter	0.000	0.987	0.013
I74.5 Embolism and thrombosis of iliac artery	0.000	0.987	0.013
C68.9 Urinary organ, unspecified	0.000	0.987	0.013
M80.95 Unspecified osteoporosis with pathological fracture (Pelvic region and thigh)	0.013	0.987	0.000
Z36.8 Other antenatal screening	0.000	0.987	0.013
Z36 Antenatal screening	0.000	0.988	0.012
M80.97 Unspecified osteoporosis with pathological fracture (Ankle and foot)	0.011	0.989	0.000
M80.96 Unspecified osteoporosis with pathological fracture (Lower leg)	0.011	0.989	0.000
M80.94 Unspecified osteoporosis with pathological fracture (Hand)	0.011	0.989	0.000
M80.93 Unspecified osteoporosis with pathological fracture (Forearm)	0.011	0.989	0.000
M80.92 Unspecified osteoporosis with pathological fracture (Upper arm)	0.011	0.989	0.000
M80.91 Unspecified osteoporosis with pathological fracture (Shoulder region)	0.011	0.989	0.000
Z36.1 Antenatal screening for raised alphafetoprotein level	0.000	0.990	0.010
I67.1 Cerebral aneurysm, nonruptured	0.010	0.990	0.000
Z36.2 Other antenatal screening based on amniocentesis	0.000	0.991	0.009
J35.0 Chronic tonsillitis	0.009	0.991	0.000
Z36.5 Antenatal screening for isoimmunisation	0.000	0.991	0.009
G81 Hemiplegia	0.000	0.991	0.009
Z36.0 Antenatal screening for chromosomal anomalies	0.000	0.992	0.008
Z36.4 Antenatal screening for foetal growth retardation using ultrasound and other physical methods	0.000	0.992	0.008
J35.1 Hypertrophy of tonsils	0.007	0.993	0.000
E03.9 Hypothyroidism, unspecified	0.000	0.993	0.007
J35 Chronic diseases of tonsils and adenoids	0.007	0.993	0.000
G81.1 Spastic hemiplegia	0.000	0.993	0.007
G81.0 Flaccid hemiplegia	0.000	0.993	0.006
J35.8 Other chronic diseases of tonsils and adenoids	0.007	0.993	0.000
E03 Other hypothyroidism	0.000	0.994	0.006
Z36.9 Antenatal screening, unspecified	0.000	0.994	0.006
E03.8 Other specified hypothyroidism	0.000	0.994	0.006
Y51 Drugs primarily affecting the autonomic nervous system	0.000	0.994	0.005
J35.3 Hypertrophy of tonsils with hypertrophy of adenoids	0.005	0.995	0.000
E03.1 Congenital hypothyroidism without goitre	0.000	0.995	0.005
C92.0 Acute myeloid leukaemia	0.005	0.995	0.000
I84.5 External haemorrhoids without complication	0.005	0.995	0.000
J35.2 Hypertrophy of adenoids	0.005	0.995	0.000
E03.0 Congenital hypothyroidism with diffuse goitre	0.000	0.995	0.005
H69.9 Eustachian tube disorder, unspecified	0.005	0.995	0.000
M80 Osteoporosis with pathological fracture	0.005	0.995	0.000
E03.5 Myxoedema coma	0.000	0.995	0.005
E03.4 Atrophy of thyroid (acquired)	0.000	0.995	0.005
E03.3 Postinfectious hypothyroidism	0.000	0.995	0.005
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.000	0.995	0.005
E03.2 Hypothyroidism due to medicaments and other exogenous substances	0.000	0.995	0.005
L30.9 Dermatitis, unspecified	0.000	0.995	0.005
H65.2 Chronic serous otitis media	0.005	0.995	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.000	0.996	0.004
Z87.5 Personal history of complications of pregnancy, childbirth and the puerperium	0.004	0.996	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.996	0.004
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.996	0.004
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.996	0.004
Y51.1 Other parasympathomimetics [cholinergics]	0.000	0.996	0.004
Y51.0 Anticholinesterase agents	0.000	0.996	0.004
N35.9 Urethral stricture, unspecified	0.000	0.996	0.004
L40.5 Arthropathic psoriasis	0.000	0.996	0.004
Y42.7 Androgens and anabolic congeners	0.004	0.996	0.000
G91.1 Obstructive hydrocephalus	0.000	0.996	0.004
E00-E07 Disorders of thyroid gland	0.000	0.996	0.004
M80.8 Other osteoporosis with pathological fracture	0.004	0.996	0.000
E07 Other disorders of thyroid	0.000	0.996	0.004
M05.90 Seropositive rheumatoid arthritis, unspecified (Multiple sites)	0.004	0.996	0.000
M05.9 Seropositive rheumatoid arthritis, unspecified	0.004	0.996	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.000	0.996	0.003
M80.4 Drug-induced osteoporosis with pathological fracture	0.004	0.996	0.000
M80.3 Postsurgical malabsorption osteoporosis with pathological fracture	0.004	0.996	0.000
M80.2 Osteoporosis of disuse with pathological fracture	0.004	0.996	0.000
M05.97 Seropositive rheumatoid arthritis, unspecified (Ankle and foot)	0.003	0.996	0.000
Z12.8 Special screening examination for neoplasm of other sites	0.004	0.996	0.000
Z12 Special screening examination for neoplasms	0.004	0.996	0.000
E07.9 Disorder of thyroid, unspecified	0.000	0.997	0.003
E02 Subclinical iodine-deficiency hypothyroidism	0.000	0.997	0.003
M80.81 Other osteoporosis with pathological fracture (Shoulder region)	0.003	0.997	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.997	0.003
D75.8 Other specified diseases of blood and blood-forming organs	0.000	0.997	0.003
M05.95 Seropositive rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.003	0.997	0.000
E05.0 Thyrotoxicosis with diffuse goitre	0.000	0.997	0.003
J35.9 Chronic disease of tonsils and adenoids, unspecified	0.003	0.997	0.000
M80.0 Postmenopausal osteoporosis with pathological fracture	0.003	0.997	0.000
S32.50 Fracture of pubis (closed)	0.003	0.997	0.000
H65.4 Other chronic nonsuppurative otitis media	0.003	0.997	0.000
K43.0 Ventral hernia with obstruction, without gangrene	0.000	0.997	0.003
E07.8 Other specified disorders of thyroid	0.000	0.997	0.003
Z12.3 Special screening examination for neoplasm of breast	0.003	0.997	0.000
M05.91 Seropositive rheumatoid arthritis, unspecified (Shoulder region)	0.003	0.997	0.000
T14.0 Superficial injury of unspecified body region	0.000	0.997	0.003
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.000	0.997	0.003
E00 Congenital iodine-deficiency syndrome	0.000	0.997	0.003
M80.89 Other osteoporosis with pathological fracture (Site unspecified)	0.003	0.997	0.000
M80.88 Other osteoporosis with pathological fracture (Other)	0.003	0.997	0.000
M80.87 Other osteoporosis with pathological fracture (Ankle and foot)	0.003	0.997	0.000
M80.86 Other osteoporosis with pathological fracture (Lower leg)	0.003	0.997	0.000
M80.85 Other osteoporosis with pathological fracture (Pelvic region and thigh)	0.003	0.997	0.000
M80.84 Other osteoporosis with pathological fracture (Hand)	0.003	0.997	0.000
M80.83 Other osteoporosis with pathological fracture (Forearm)	0.003	0.997	0.000
M80.82 Other osteoporosis with pathological fracture (Upper arm)	0.003	0.997	0.000
M80.80 Other osteoporosis with pathological fracture (Multiple sites)	0.003	0.997	0.000
M80.5 Idiopathic osteoporosis with pathological fracture	0.003	0.997	0.000
Chapter IV Endocrine, nutritional and metabolic diseases	0.000	0.997	0.003
M41.99 Scoliosis, unspecified (Site unspecified)	0.000	0.997	0.003
E78.5 Hyperlipidaemia, unspecified	0.000	0.997	0.003
M21.16 Varus deformity, not elsewhere classified (Lower leg)	0.003	0.997	0.000
E07.1 Dyshormogenetic goitre	0.000	0.997	0.003
E07.0 Hypersecretion of calcitonin	0.000	0.997	0.003
O82.0 Delivery by elective Caesarean section	0.000	0.997	0.003
H65 Nonsuppurative otitis media	0.003	0.997	0.000
M80.1 Postoophorectomy osteoporosis with pathological fracture	0.003	0.997	0.000
Z12.4 Special screening examination for neoplasm of cervix	0.003	0.997	0.000
E06 Thyroiditis	0.000	0.997	0.003
M05.99 Seropositive rheumatoid arthritis, unspecified (Site unspecified)	0.003	0.997	0.000
M05.98 Seropositive rheumatoid arthritis, unspecified (Other)	0.003	0.997	0.000
M05.93 Seropositive rheumatoid arthritis, unspecified (Forearm)	0.003	0.997	0.000
M80.29 Osteoporosis of disuse with pathological fracture (Site unspecified)	0.003	0.997	0.000
M80.28 Osteoporosis of disuse with pathological fracture (Other)	0.003	0.997	0.000
M80.27 Osteoporosis of disuse with pathological fracture (Ankle and foot)	0.003	0.997	0.000
M80.26 Osteoporosis of disuse with pathological fracture (Lower leg)	0.003	0.997	0.000
M80.25 Osteoporosis of disuse with pathological fracture (Pelvic region and thigh)	0.003	0.997	0.000
M80.24 Osteoporosis of disuse with pathological fracture (Hand)	0.003	0.997	0.000
M80.23 Osteoporosis of disuse with pathological fracture (Forearm)	0.003	0.997	0.000
M80.22 Osteoporosis of disuse with pathological fracture (Upper arm)	0.003	0.997	0.000
M80.21 Osteoporosis of disuse with pathological fracture (Shoulder region)	0.003	0.997	0.000
M80.20 Osteoporosis of disuse with pathological fracture (Multiple sites)	0.003	0.997	0.000
M80.39 Postsurgical malabsorption osteoporosis with pathological fracture (Site unspecified)	0.003	0.997	0.000
M80.38 Postsurgical malabsorption osteoporosis with pathological fracture (Other)	0.003	0.997	0.000
M80.37 Postsurgical malabsorption osteoporosis with pathological fracture (Ankle and foot)	0.003	0.997	0.000
M80.36 Postsurgical malabsorption osteoporosis with pathological fracture (Lower leg)	0.003	0.997	0.000
M80.35 Postsurgical malabsorption osteoporosis with pathological fracture (Pelvic region and thigh)	0.003	0.997	0.000
M80.34 Postsurgical malabsorption osteoporosis with pathological fracture (Hand)	0.003	0.997	0.000
M80.33 Postsurgical malabsorption osteoporosis with pathological fracture (Forearm)	0.003	0.997	0.000
M80.32 Postsurgical malabsorption osteoporosis with pathological fracture (Upper arm)	0.003	0.997	0.000
M80.31 Postsurgical malabsorption osteoporosis with pathological fracture (Shoulder region)	0.003	0.997	0.000
M80.30 Postsurgical malabsorption osteoporosis with pathological fracture (Multiple sites)	0.003	0.997	0.000
M80.49 Drug-induced osteoporosis with pathological fracture (Site unspecified)	0.003	0.997	0.000
M80.48 Drug-induced osteoporosis with pathological fracture (Other)	0.003	0.997	0.000
M80.47 Drug-induced osteoporosis with pathological fracture (Ankle and foot)	0.003	0.997	0.000
M80.46 Drug-induced osteoporosis with pathological fracture (Lower leg)	0.003	0.997	0.000
M80.45 Drug-induced osteoporosis with pathological fracture (Pelvic region and thigh)	0.003	0.997	0.000
M80.44 Drug-induced osteoporosis with pathological fracture (Hand)	0.003	0.997	0.000
M80.43 Drug-induced osteoporosis with pathological fracture (Forearm)	0.003	0.997	0.000
M80.42 Drug-induced osteoporosis with pathological fracture (Upper arm)	0.003	0.997	0.000
M80.41 Drug-induced osteoporosis with pathological fracture (Shoulder region)	0.003	0.997	0.000
M80.40 Drug-induced osteoporosis with pathological fracture (Multiple sites)	0.003	0.997	0.000
M05.92 Seropositive rheumatoid arthritis, unspecified (Upper arm)	0.003	0.997	0.000
M05.94 Seropositive rheumatoid arthritis, unspecified (Hand)	0.003	0.997	0.000
E05 Thyrotoxicosis [hyperthyroidism]	0.000	0.997	0.003
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.003	0.997	0.000
M05 Seropositive rheumatoid arthritis	0.003	0.997	0.000
D75.1 Secondary polycythaemia	0.000	0.997	0.003
I08.3 Combined disorders of mitral, aortic and tricuspid valves	0.003	0.997	0.000
G80-G83 Cerebral palsy and other paralytic syndromes	0.000	0.997	0.003
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.003	0.997	0.000
M80.09 Postmenopausal osteoporosis with pathological fracture (Site unspecified)	0.002	0.997	0.000
M80.08 Postmenopausal osteoporosis with pathological fracture (Other)	0.002	0.997	0.000
M80.07 Postmenopausal osteoporosis with pathological fracture (Ankle and foot)	0.002	0.997	0.000
M80.06 Postmenopausal osteoporosis with pathological fracture (Lower leg)	0.002	0.997	0.000
M80.05 Postmenopausal osteoporosis with pathological fracture (Pelvic region and thigh)	0.002	0.997	0.000
M80.04 Postmenopausal osteoporosis with pathological fracture (Hand)	0.002	0.997	0.000
M80.03 Postmenopausal osteoporosis with pathological fracture (Forearm)	0.002	0.997	0.000
M80.02 Postmenopausal osteoporosis with pathological fracture (Upper arm)	0.002	0.997	0.000
M80.01 Postmenopausal osteoporosis with pathological fracture (Shoulder region)	0.002	0.997	0.000
R41.3 Other amnesia	0.000	0.997	0.003
Y42.0 Glucocorticoids and synthetic analogs	0.003	0.997	0.000
D43.0 Brain, supratentorial	0.003	0.997	0.000
D75 Other diseases of blood and blood-forming organs	0.000	0.997	0.003
M05.96 Seropositive rheumatoid arthritis, unspecified (Lower leg)	0.002	0.997	0.000
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.003	0.997	0.000
G91.0 Communicating hydrocephalus	0.000	0.997	0.003
E14.9 Without complications	0.000	0.997	0.003
G82.5 Tetraplegia, unspecified	0.000	0.997	0.003
Y42.5 Other oestrogens and progestogens	0.003	0.997	0.000
Z12.5 Special screening examination for neoplasm of prostate	0.003	0.997	0.000
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)	0.003	0.997	0.000
Z12.6 Special screening examination for neoplasm of bladder	0.002	0.997	0.000
E00.9 Congenital iodine-deficiency syndrome, unspecified	0.000	0.997	0.002
E00.2 Congenital iodine-deficiency syndrome, mixed type	0.000	0.997	0.002
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type	0.000	0.997	0.002
E00.0 Congenital iodine-deficiency syndrome, neurological type	0.000	0.997	0.002
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions	0.000	0.997	0.002
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified	0.000	0.997	0.002
E01.1 Iodine-deficiency-related multinodular (endemic) goitre	0.000	0.997	0.002
E01.0 Iodine-deficiency-related diffuse (endemic) goitre	0.000	0.997	0.002
M05.8 Other seropositive rheumatoid arthritis	0.002	0.997	0.000
M80.59 Idiopathic osteoporosis with pathological fracture (Site unspecified)	0.002	0.997	0.000
M80.58 Idiopathic osteoporosis with pathological fracture (Other)	0.002	0.997	0.000
M80.57 Idiopathic osteoporosis with pathological fracture (Ankle and foot)	0.002	0.997	0.000
M80.56 Idiopathic osteoporosis with pathological fracture (Lower leg)	0.002	0.997	0.000
M80.55 Idiopathic osteoporosis with pathological fracture (Pelvic region and thigh)	0.002	0.997	0.000
M80.54 Idiopathic osteoporosis with pathological fracture (Hand)	0.002	0.997	0.000
M80.53 Idiopathic osteoporosis with pathological fracture (Forearm)	0.002	0.997	0.000
M80.51 Idiopathic osteoporosis with pathological fracture (Shoulder region)	0.002	0.997	0.000
E06.9 Thyroiditis, unspecified	0.000	0.997	0.002
E78.8 Other disorders of lipoprotein metabolism	0.000	0.997	0.002
M05.1 Rheumatoid lung disease	0.002	0.997	0.000
S52.10 Fracture of upper end of radius (closed)	0.000	0.998	0.002
H65.1 Other acute nonsuppurative otitis media	0.002	0.998	0.000
M06.94 Rheumatoid arthritis, unspecified (Hand)	0.002	0.998	0.000
Z12.2 Special screening examination for neoplasm of respiratory organs	0.002	0.998	0.000
M05.80 Other seropositive rheumatoid arthritis (Multiple sites)	0.002	0.998	0.000
B50.9 Plasmodium falciparum malaria, unspecified	0.002	0.998	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.002	0.998	0.000
M80.19 Postoophorectomy osteoporosis with pathological fracture (Site unspecified)	0.002	0.998	0.000
M80.18 Postoophorectomy osteoporosis with pathological fracture (Other)	0.002	0.998	0.000
M80.17 Postoophorectomy osteoporosis with pathological fracture (Ankle and foot)	0.002	0.998	0.000
M80.16 Postoophorectomy osteoporosis with pathological fracture (Lower leg)	0.002	0.998	0.000
M80.15 Postoophorectomy osteoporosis with pathological fracture (Pelvic region and thigh)	0.002	0.998	0.000
M80.14 Postoophorectomy osteoporosis with pathological fracture (Hand)	0.002	0.998	0.000
M80.13 Postoophorectomy osteoporosis with pathological fracture (Forearm)	0.002	0.998	0.000
M80.12 Postoophorectomy osteoporosis with pathological fracture (Upper arm)	0.002	0.998	0.000
M80.11 Postoophorectomy osteoporosis with pathological fracture (Shoulder region)	0.002	0.998	0.000
E06.4 Drug-induced thyroiditis	0.000	0.998	0.002
E06.2 Chronic thyroiditis with transient thyrotoxicosis	0.000	0.998	0.002
E06.0 Acute thyroiditis	0.000	0.998	0.002
M05.10 Rheumatoid lung disease (Multiple sites)	0.002	0.998	0.000
G83.9 Paralytic syndrome, unspecified	0.000	0.998	0.002
H65.0 Acute serous otitis media	0.002	0.998	0.000
E06.5 Other chronic thyroiditis	0.000	0.998	0.002
E78.2 Mixed hyperlipidaemia	0.000	0.998	0.002
N76.0 Acute vaginitis	0.000	0.998	0.002
D75.9 Disease of blood and blood-forming organs, unspecified	0.000	0.998	0.002
E78.1 Pure hyperglyceridaemia	0.000	0.998	0.002
E78 Disorders of lipoprotein metabolism and other lipidaemias	0.000	0.998	0.002
H69 Other disorders of Eustachian tube	0.002	0.998	0.000
M80.50 Idiopathic osteoporosis with pathological fracture (Multiple sites)	0.002	0.998	0.000
C92 Myeloid leukaemia	0.002	0.998	0.000
K52.1 Toxic gastro-enteritis and colitis	0.000	0.998	0.002
M05.2 Rheumatoid vasculitis	0.002	0.998	0.000
Y42.9 Other and unspecified hormone antagonists	0.002	0.998	0.000
Z12.9 Special screening examination for neoplasm, unspecified	0.002	0.998	0.000
M80.00 Postmenopausal osteoporosis with pathological fracture (Multiple sites)	0.002	0.998	0.000
E05.5 Thyroid crisis or storm	0.000	0.998	0.002
E05.4 Thyrotoxicosis factitia	0.000	0.998	0.002
E05.3 Thyrotoxicosis from ectopic thyroid tissue	0.000	0.998	0.002
E05.1 Thyrotoxicosis with toxic single thyroid nodule	0.000	0.998	0.002
F34.1 Dysthymia	0.002	0.998	0.000
Y42.2 Antithyroid drugs	0.002	0.998	0.000
G83 Other paralytic syndromes	0.000	0.998	0.002
M05.3 Rheumatoid arthritis with involvement of other organs and systems	0.002	0.998	0.000
M05.0 Felty's syndrome	0.002	0.998	0.000
G82 Paraplegia and tetraplegia	0.000	0.998	0.002
E78.9 Disorder of lipoprotein metabolism, unspecified	0.000	0.998	0.002
L73.9 Follicular disorder, unspecified	0.002	0.998	0.000
D75.0 Familial erythrocytosis	0.000	0.998	0.002
E05.8 Other thyrotoxicosis	0.000	0.998	0.002
Y42.4 Oral contraceptives	0.002	0.998	0.000
M80.52 Idiopathic osteoporosis with pathological fracture (Upper arm)	0.002	0.998	0.000
C92.5 Acute myelomonocytic leukaemia	0.002	0.998	0.000
D75.2 Essential thrombocytosis	0.000	0.998	0.002
E06.3 Autoimmune thyroiditis	0.000	0.998	0.002
E06.1 Subacute thyroiditis	0.000	0.998	0.002
I22.9 Subsequent myocardial infarction of unspecified site	0.000	0.998	0.002
E66.8 Other obesity	0.000	0.998	0.002
E78.4 Other hyperlipidaemia	0.000	0.998	0.002
H65.9 Nonsuppurative otitis media, unspecified	0.002	0.998	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.998	0.002
M05.89 Other seropositive rheumatoid arthritis (Site unspecified)	0.002	0.998	0.000
M05.88 Other seropositive rheumatoid arthritis (Other)	0.002	0.998	0.000
M05.87 Other seropositive rheumatoid arthritis (Ankle and foot)	0.002	0.998	0.000
M05.86 Other seropositive rheumatoid arthritis (Lower leg)	0.002	0.998	0.000
M05.85 Other seropositive rheumatoid arthritis (Pelvic region and thigh)	0.002	0.998	0.000
M05.84 Other seropositive rheumatoid arthritis (Hand)	0.002	0.998	0.000
M05.83 Other seropositive rheumatoid arthritis (Forearm)	0.002	0.998	0.000
M05.82 Other seropositive rheumatoid arthritis (Upper arm)	0.002	0.998	0.000
M05.81 Other seropositive rheumatoid arthritis (Shoulder region)	0.002	0.998	0.000
M05.19 Rheumatoid lung disease (Site unspecified)	0.002	0.998	0.000
M05.18 Rheumatoid lung disease (Other)	0.002	0.998	0.000
M05.17 Rheumatoid lung disease (Ankle and foot)	0.002	0.998	0.000
M05.16 Rheumatoid lung disease (Lower leg)	0.002	0.998	0.000
M05.15 Rheumatoid lung disease (Pelvic region and thigh)	0.002	0.998	0.000
M05.14 Rheumatoid lung disease (Hand)	0.002	0.998	0.000
M05.13 Rheumatoid lung disease (Forearm)	0.002	0.998	0.000
M05.12 Rheumatoid lung disease (Upper arm)	0.002	0.998	0.000
M05.11 Rheumatoid lung disease (Shoulder region)	0.002	0.998	0.000
M07.36 Other psoriatic arthropathies (Lower leg)	0.000	0.998	0.002
M06.9 Rheumatoid arthritis, unspecified	0.002	0.998	0.000
R41.8 Other and unspecified symptoms and signs involving cognitive functions and awareness	0.000	0.998	0.002
G91 Hydrocephalus	0.000	0.998	0.002
Z29.1 Prophylactic immunotherapy	0.002	0.998	0.000
G83.1 Monoplegia of lower limb	0.000	0.998	0.002
R57.2 Septic shock	0.000	0.998	0.002
M05.20 Rheumatoid vasculitis (Multiple sites)	0.002	0.998	0.000
M06.93 Rheumatoid arthritis, unspecified (Forearm)	0.002	0.998	0.000
L42 Pityriasis rosea	0.000	0.998	0.002
S02.00 Fracture of vault of skull (closed)	0.000	0.998	0.002
C92.4 Acute promyelocytic leukaemia	0.002	0.998	0.000
H69.0 Patulous Eustachian tube	0.002	0.998	0.000
E65-E68 Obesity and other hyperalimentation	0.000	0.998	0.002
M06.98 Rheumatoid arthritis, unspecified (Other)	0.002	0.998	0.000
M05.28 Rheumatoid vasculitis (Other)	0.002	0.998	0.000
M05.27 Rheumatoid vasculitis (Ankle and foot)	0.002	0.998	0.000
M05.26 Rheumatoid vasculitis (Lower leg)	0.002	0.998	0.000
M05.25 Rheumatoid vasculitis (Pelvic region and thigh)	0.002	0.998	0.000
M05.24 Rheumatoid vasculitis (Hand)	0.002	0.998	0.000
M05.23 Rheumatoid vasculitis (Forearm)	0.002	0.998	0.000
M05.22 Rheumatoid vasculitis (Upper arm)	0.002	0.998	0.000
M05.21 Rheumatoid vasculitis (Shoulder region)	0.002	0.998	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.002	0.998	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.002	0.998	0.000
C92.3 Myeloid sarcoma	0.002	0.998	0.000
C92.2 Subacute myeloid leukaemia	0.002	0.998	0.000
D43.2 Brain, unspecified	0.002	0.998	0.000
O99.0 Anaemia complicating pregnancy, childbirth and the puerperium	0.000	0.998	0.002
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system	0.002	0.998	0.000
M05.29 Rheumatoid vasculitis (Site unspecified)	0.002	0.998	0.000
D43.4 Spinal cord	0.002	0.998	0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.000	0.998	0.002
M05.09 Felty's syndrome (Site unspecified)	0.002	0.998	0.000
M05.08 Felty's syndrome (Other)	0.002	0.998	0.000
M05.07 Felty's syndrome (Ankle and foot)	0.002	0.998	0.000
M05.06 Felty's syndrome (Lower leg)	0.002	0.998	0.000
M05.05 Felty's syndrome (Pelvic region and thigh)	0.002	0.998	0.000
M05.04 Felty's syndrome (Hand)	0.002	0.998	0.000
M05.03 Felty's syndrome (Forearm)	0.002	0.998	0.000
M05.02 Felty's syndrome (Upper arm)	0.002	0.998	0.000
M05.01 Felty's syndrome (Shoulder region)	0.002	0.998	0.000
M05.00 Felty's syndrome (Multiple sites)	0.002	0.998	0.000
M05.39 Rheumatoid arthritis with involvement of other organs and systems (Site unspecified)	0.002	0.998	0.000
M05.38 Rheumatoid arthritis with involvement of other organs and systems (Other)	0.002	0.998	0.000
M05.37 Rheumatoid arthritis with involvement of other organs and systems (Ankle and foot)	0.002	0.998	0.000
M05.36 Rheumatoid arthritis with involvement of other organs and systems (Lower leg)	0.002	0.998	0.000
M05.35 Rheumatoid arthritis with involvement of other organs and systems (Pelvic region and thigh)	0.002	0.998	0.000
M05.34 Rheumatoid arthritis with involvement of other organs and systems (Hand)	0.002	0.998	0.000
M05.33 Rheumatoid arthritis with involvement of other organs and systems (Forearm)	0.002	0.998	0.000
M05.32 Rheumatoid arthritis with involvement of other organs and systems (Upper arm)	0.002	0.998	0.000
M05.31 Rheumatoid arthritis with involvement of other organs and systems (Shoulder region)	0.002	0.998	0.000
M05.30 Rheumatoid arthritis with involvement of other organs and systems (Multiple sites)	0.002	0.998	0.000
D12.0 Caecum	0.000	0.998	0.002
G82.3 Flaccid tetraplegia	0.000	0.998	0.002
G82.0 Flaccid paraplegia	0.000	0.998	0.002
G83.5 Locked-in syndrome	0.000	0.998	0.002
G83.3 Monoplegia, unspecified	0.000	0.998	0.002
G83.0 Diplegia of upper limbs	0.000	0.998	0.002
Y42.1 Thyroid hormones and substitutes	0.002	0.998	0.000
E78.6 Lipoprotein deficiency	0.000	0.998	0.002
S32.5 Fracture of pubis	0.002	0.998	0.000
Z08.0 Follow-up examination after surgery for malignant neoplasm	0.000	0.998	0.002
L30 Other dermatitis	0.000	0.998	0.002
G82.4 Spastic tetraplegia	0.000	0.998	0.002
M07.3 Other psoriatic arthropathies	0.000	0.998	0.002
E40-E46 Malnutrition	0.000	0.998	0.002
H61.0 Perichondritis of external ear	0.002	0.998	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.998	0.002
M07.39 Other psoriatic arthropathies (Site unspecified)	0.000	0.998	0.002
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)	0.000	0.998	0.002
M06.92 Rheumatoid arthritis, unspecified (Upper arm)	0.002	0.998	0.000
C92.9 Myeloid leukaemia, unspecified	0.002	0.998	0.000
G83.2 Monoplegia of upper limb	0.000	0.998	0.002
L40 Psoriasis	0.000	0.998	0.002
M19.90 Arthrosis, unspecified (Multiple sites)	0.000	0.998	0.002
M79.25 Neuralgia and neuritis, unspecified (Pelvic region and thigh)	0.000	0.998	0.002
H65.3 Chronic mucoid otitis media	0.002	0.998	0.000
C92.7 Other myeloid leukaemia	0.002	0.998	0.000
C92.1 Chronic myeloid leukaemia	0.002	0.998	0.000
D05.9 Carcinoma in situ of breast, unspecified	0.002	0.998	0.000
G91.3 Posttraumatic hydrocephalus, unspecified	0.000	0.998	0.002
M41.95 Scoliosis, unspecified (Thoracolumbar region)	0.000	0.998	0.002
H02.9 Disorder of eyelid, unspecified	0.000	0.998	0.002
G82.1 Spastic paraplegia	0.000	0.998	0.002
H69.8 Other specified disorders of Eustachian tube	0.002	0.998	0.000
I84.0 Internal thrombosed haemorrhoids	0.002	0.998	0.000
N64.4 Mastodynia	0.002	0.998	0.000
M25.50 Pain in joint (Multiple sites)	0.002	0.998	0.000
Q85.0 Neurofibromatosis (nonmalignant)	0.000	0.998	0.002
Z41.1 Other plastic surgery for unacceptable cosmetic appearance	0.000	0.998	0.002
L40.8 Other psoriasis	0.000	0.998	0.002
R41.1 Anterograde amnesia	0.000	0.998	0.002
R57.0 Cardiogenic shock	0.000	0.998	0.002
E67 Other hyperalimentation	0.000	0.998	0.002
E68 Sequelae of hyperalimentation	0.000	0.998	0.002
R41 Other symptoms and signs involving cognitive functions and awareness	0.000	0.998	0.002
M88.90 Paget's disease of bone, unspecified (Multiple sites)	0.000	0.998	0.002
S06.60 Traumatic subarachnoid haemorrhage (without open intracranial wound)	0.000	0.998	0.002
L30.1 Dyshidrosis [pompholyx]	0.000	0.998	0.002
M21.1 Varus deformity, not elsewhere classified	0.002	0.998	0.000
M07.30 Other psoriatic arthropathies (Multiple sites)	0.000	0.998	0.002
S06.80 Other intracranial injuries (without open intracranial wound)	0.000	0.998	0.002
D43.9 Central nervous system, unspecified	0.002	0.998	0.000
D43.7 Other parts of central nervous system	0.002	0.998	0.000
D43.3 Cranial nerves	0.002	0.998	0.000
E78.3 Hyperchylomicronaemia	0.000	0.998	0.001
G91.2 Normal-pressure hydrocephalus	0.000	0.998	0.002
I70.00 Atherosclerosis of aorta (without gangrene)	0.000	0.998	0.002
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
D43.1 Brain, infratentorial	0.002	0.998	0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre	0.000	0.998	0.001
I20.1 Angina pectoris with documented spasm	0.000	0.998	0.002
K75.4 Autoimmune hepatitis	0.002	0.998	0.000
O62.0 Primary inadequate contractions	0.000	0.998	0.002
E15 Nondiabetic hypoglycaemic coma	0.000	0.998	0.001
T14 Injury of unspecified body region	0.000	0.998	0.002
M07.31 Other psoriatic arthropathies (Shoulder region)	0.000	0.998	0.001
M80.10 Postoophorectomy osteoporosis with pathological fracture (Multiple sites)	0.001	0.998	0.000
S32.51 Fracture of pubis (open)	0.001	0.998	0.000
C69.3 Choroid	0.002	0.998	0.000
L30.5 Pityriasis alba	0.000	0.998	0.001
L30.2 Cutaneous autosensitisation	0.000	0.998	0.001
L30.0 Nummular dermatitis	0.000	0.998	0.001
M07.38 Other psoriatic arthropathies (Other)	0.000	0.998	0.001
M07.37 Other psoriatic arthropathies (Ankle and foot)	0.000	0.998	0.001
M07.33 Other psoriatic arthropathies (Forearm)	0.000	0.998	0.001
M07.32 Other psoriatic arthropathies (Upper arm)	0.000	0.998	0.001
G83.8 Other specified paralytic syndromes	0.000	0.998	0.001
L40.4 Guttate psoriasis	0.000	0.998	0.002
E44 Protein-energy malnutrition of moderate and mild degree	0.000	0.998	0.001
E45 Retarded development following protein-energy malnutrition	0.000	0.998	0.001
E43 Unspecified severe protein-energy malnutrition	0.000	0.998	0.001
E42 Marasmic kwashiorkor	0.000	0.998	0.001
E41 Nutritional marasmus	0.000	0.998	0.001
E40 Kwashiorkor	0.000	0.998	0.001
I74 Arterial embolism and thrombosis	0.000	0.998	0.002
S22.20 Fracture of sternum (closed)	0.002	0.998	0.000
I74.8 Embolism and thrombosis of other arteries	0.000	0.998	0.002
L30.4 Erythema intertrigo	0.000	0.998	0.001
L40.3 Pustulosis palmaris et plantaris	0.000	0.998	0.001
L40.2 Acrodermatitis continua	0.000	0.998	0.001
M41.9 Scoliosis, unspecified	0.000	0.998	0.002
N77.1 Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere	0.000	0.998	0.002
T84.5 Infection and inflammatory reaction due to internal joint prosthesis	0.002	0.998	0.000
S02.20 Fracture of nasal bones (closed)	0.000	0.998	0.002
B50 Plasmodium falciparum malaria	0.001	0.998	0.000
M21.15 Varus deformity, not elsewhere classified (Pelvic region and thigh)	0.001	0.998	0.000
C15.5 Lower third of oesophagus	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations